PortfoliosLab logoPortfoliosLab logo
MDXG vs. TNGX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MDXG vs. TNGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MiMedx Group, Inc. (MDXG) and Tango Therapeutics, Inc. (TNGX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDXG achieves a -39.00% return, which is significantly lower than TNGX's 206.77% return.


MDXG

1D
-3.28%
1M
4.56%
6M
-19.18%
YTD
-39.00%
1Y
-42.32%
3Y*
-19.54%
5Y*
-19.56%
10Y*
-5.84%
ALL TIME*
14.68%

TNGX

1D
-1.41%
1M
-7.74%
6M
134.11%
YTD
206.77%
1Y
316.23%
3Y*
102.77%
5Y*
22.08%
10Y*
ALL TIME*
18.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$7.26M$5.86M$5.57M
$60.56M$71.36M$111.26M

MDXG vs. TNGX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
MDXG
MiMedx Group, Inc.
-39.00%-29.63%9.69%215.47%-53.97%-33.48%35.52%
TNGX
Tango Therapeutics, Inc.
206.77%186.73%-68.79%36.55%-33.73%-4.37%15.79%

Correlation

The correlation between MDXG and TNGX is 0.08, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.08

Correlation (3Y)
Balances recent behavior with more history.

0.21

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.24

Correlation (All Time)
Calculated using the full available price history since Sep 3, 2020

0.22

The correlation between MDXG and TNGX shifts across timeframes, from 0.08 (1 year) to 0.24 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MDXG:

$601.99M

TNGX:

$3.38B

EPS

MDXG:

$0.04

TNGX:

-$0.87

PS Ratio

MDXG:

1.73

TNGX:

58.93

PB Ratio

MDXG:

2.83

TNGX:

9.97

Total Revenue (TTM)

MDXG:

$355.17M

TNGX:

$56.99M

Gross Profit (TTM)

MDXG:

$280.05M

TNGX:

$55.33M

EBITDA (TTM)

MDXG:

$22.16M

TNGX:

-$111.92M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDXG vs. TNGX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MDXG
MDXG Risk / Return Rank: 1010
Overall Rank
MDXG Sharpe Ratio Rank: 44
Sharpe Ratio Rank
MDXG Sortino Ratio Rank: 66
Sortino Ratio Rank
MDXG Omega Ratio Rank: 77
Omega Ratio Rank
MDXG Calmar Ratio Rank: 1717
Calmar Ratio Rank
MDXG Martin Ratio Rank: 1616
Martin Ratio Rank

TNGX
TNGX Risk / Return Rank: 9898
Overall Rank
TNGX Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
TNGX Sortino Ratio Rank: 9797
Sortino Ratio Rank
TNGX Omega Ratio Rank: 9696
Omega Ratio Rank
TNGX Calmar Ratio Rank: 9999
Calmar Ratio Rank
TNGX Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MDXG vs. TNGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and Tango Therapeutics, Inc. (TNGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MDXGTNGXDifference
Sharpe ratioReturn per unit of total volatility

-4.56

Sortino ratioReturn per unit of downside risk

-5.54

Omega ratioGain probability vs. loss probability

0.82

1.50

-0.68

Calmar ratioReturn relative to maximum drawdown

-0.70

12.06

-12.76

Martin ratioReturn relative to average drawdown

-1.19

29.31

-30.50

MDXG vs. TNGX - Sharpe Ratio Comparison

The current MDXG Sharpe Ratio is -1.06, which is lower than the TNGX Sharpe Ratio of 3.50. The chart below compares the historical Sharpe Ratios of MDXG and TNGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MDXG vs. TNGX - Drawdown Comparison

The maximum MDXG drawdown since its inception was -93.83%, roughly equal to the maximum TNGX drawdown of -93.64%. Use the drawdown chart below to compare losses from any high point for MDXG and TNGX.


Loading charts...

Drawdown Indicators


MDXGTNGXDifference

Max Drawdown

Largest peak-to-trough decline

-93.83%

-93.64%

-0.19%

Max Drawdown (1Y)

Largest decline over 1 year

-61.24%

-29.24%

-32.00%

Max Drawdown (3Y)

Largest decline over 3 years

-68.36%

-91.46%

+23.10%

Max Drawdown (5Y)

Largest decline over 5 years

-83.39%

-93.64%

+10.25%

Max Drawdown (10Y)

Largest decline over 10 years

-93.60%

Current Drawdown

Current decline from peak

-77.00%

-17.39%

-59.61%

Average Drawdown

Average peak-to-trough decline

-53.70%

-47.16%

-6.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.92%

12.01%

+23.91%

Volatility

MDXG vs. TNGX - Volatility Comparison

The current volatility for MiMedx Group, Inc. (MDXG) is 10.70%, while Tango Therapeutics, Inc. (TNGX) has a volatility of 18.65%. This indicates that MDXG experiences smaller price fluctuations and is considered to be less risky than TNGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDXGTNGXDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.70%

18.65%

-7.95%

Volatility (6M)

Calculated over the trailing 6-month period

30.96%

74.78%

-43.82%

Volatility (1Y)

Calculated over the trailing 1-year period

41.60%

100.91%

-59.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.44%

102.52%

-41.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.88%

95.56%

-21.68%

Dividends

MDXG vs. TNGX - Dividend Comparison

Neither MDXG nor TNGX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

MDXG vs. TNGX - Financials Comparison

This section allows you to compare key financial metrics between MiMedx Group, Inc. and Tango Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


MDXG and TNGX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TNGX has higher volatility (18.65%) compared to MDXG (10.70%). In terms of maximum drawdown, MDXG dropped -93.83% vs TNGX's -93.64%.

TNGX currently has the higher Sharpe Ratio (3.50 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDXG and TNGX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer